Peripheral CD4 + T Cells Predict T Cell Immunity in Lung Tissues of Non-small Cell Lung Cancer Patients
Anticancer Research · 2025
DOI: 10.21873/anticanres.17478 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Mari Tone und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Immunotherapy, Osaka International Cancer Institute, Osaka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, CD4-Positive T-Lymphocytes, Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background/Aim: Previous investigations showed that non-small cell lung cancer (NSCLC) patients with a high percentage of a peripheral CD4+ T cell subset were more likely to have severe immune-related adverse events (irAEs) due to anti-PD-1 therapy. The present study investigated the relationship between a peripheral CD4+ T cell subset and T cell immunity in the non-tumor lung tissues of patients with NSCLC to clarify the rationale of predictive biomarkers for anti-PD-1-related pneumonitis. Patients and Methods: We analyzed the T cell profiles and functions in peripheral blood and non-tumor lung tissues surgically resected from patients with NSCLC.
Results
In patients with NSCLC with a high percentage of the peripheral CD4+ T cell subset (CD45RA+CD25+CD4+ T cells), non-tumor lung tissues had a high percentage of PD-1+CD4+ T cells and a low percentage of PD-1+ effector regulatory T (Treg) cells. The percentage of PD-1+ effector Treg cells negatively correlated with IFNγ and TNFα production by CD4+ T cells in the lung tissues of patients with NSCLC.
Conclusion
Patients with NSCLC with a high percentage of the peripheral CD4+ T cell subset are at an increased risk of anti-PD-1-related pneumonitis, which activates PD-1+CD4+ T cells in the absence of the suppressive activity of effector Treg cells in lung tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Immunotherapy, Osaka International Cancer Institute, Osaka, Japan.
- Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, Osaka University, Suita, Japan.
- Department of Clinical Research in Tumor Immunology, Graduate School of Medicine, Osaka University, Suita, Japan.
- Department of General Thoracic Surgery, Graduate School of Medicine, Osaka University, Suita, Japan.
- Department of Immunopathology, World Premier International Research Center Initiative (WPI), Immunology Frontier Research Center (IFReC), Osaka University, Suita, Japan.
- Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Suita, Japan.
Zitieren
APA
Tone, M., Isono, T., Yamamoto, Y., Takeda, Y., Shintani, Y., Kumanogoh, A., Wada, H., & Iwahori, K. (2025). Peripheral CD4 + T Cells Predict T Cell Immunity in Lung Tissues of Non-small Cell Lung Cancer Patients. Anticancer Research. https://doi.org/10.21873/anticanres.17478
Vancouver
Tone M, Isono T, Yamamoto Y, Takeda Y, Shintani Y, Kumanogoh A, et al. Peripheral CD4 + T Cells Predict T Cell Immunity in Lung Tissues of Non-small Cell Lung Cancer Patients. Anticancer Research. 2025. doi:10.21873/anticanres.17478
BibTeX
@article{Tone2025,
author = {Tone, Mari and Isono, Tomomi and Yamamoto, Yoko and Takeda, Yoshito and Shintani, Yasushi and Kumanogoh, Atsushi and Wada, Hisashi and Iwahori, Kota},
title = {Peripheral CD4 + T Cells Predict T Cell Immunity in Lung Tissues of Non-small Cell Lung Cancer Patients},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17478}
}
EUVIMED